Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: Relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers

Blood

Volumn 87, Issue 9, 1996, Pages 3963-3969

  Kirkland, Mark A ^a   Spencer, Andrew ^a   Davidson, R John ^a   McDonald, Christine ^a   Goldman, John M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAFOSFAMIDE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RECOMBINANT STEM CELL FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CELL COUNT; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; HUMANS; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029970344     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3963.bloodjournal8793963     Document Type: Article

References (31)

1. Ma DD, Varga DE, Biggs JC: Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: Recovery of haemopoietic progenitors (CFU-Mix, BFU-E and CFU-GM). Br J Haematol 65:5, 1987
2. Vellenga E, Sizoo W, Hagenbeek A, Lowenberg B. Different repopulation kinetics of crythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation. Br J Haematol 65:137, 1987
3. Thomas MR, Robinson WA, Mughal TI, Morton N, Glode LM. Recovery of blood and bone marrow stem cells following intense chemotherapy and autologous bone marrow transplantation. Oncology 43:273, 1986
4. Neben S, Hemman S, Montgomery M, Ferrara J, Mauch P: Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 21:156, 1993
5. Mauch P, Rosenblatt M, Hellman S: Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood 72:1193, 1988
6. Mauch P, Ferrara J, Hellman S: Stem cell self-renewal considerations in bone marrow transplantation. Bone Marrow Transplant 4:601, 1989
7. Mauch P, Hellman S: Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood 74:872, 1989
8. Gardner RV, Astle CM, Harrison DE: The decrease in long-term marrow repopulating capacity seen after transplantation is not the result of irradiation-induced stromal injury. Exp Hematol 16:49, 1988
9. Moore MA: Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78:1, 1991
10. Gordon MY, Goldman JM, Gordon-Smith EC: 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte-macrophage colony forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res 9:1017, 1985
11. Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614, 1981
12. Ogawa M, Porter PN, Nakahata T: Renewal and commitment to differentiation of hemopoietic stem cells (an interpretive review). Blood 61:823, 1983
13. Till JE, McCulloch EA, Siminovitch L: A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming units. Proc Natl Acad Sci USA 51:29, 1964
14. Carlo Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V: Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: Implications for adjusted dose purging in autologous bone marrow transplantation. Exp Hematol 20:328, 1992
15. Winton EF, Colenda KW: Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide. Exp Hematol 15: 710, 1987
16. Nagler A, Mumcuoglu M, Naparstek E, Or R, Gan S, Slavin S: Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth. Leuk Res 17:61, 1993
17. Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM: Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. Bone Marrow Transplant 7:183, 1991
18. Beaujean F, Hartmann O, Benhamou E, Lemerle J, Duedari N: Hemopoietic reconstitution after repeated autologous transplantation with mafosfamide-purged marrow. Bone Marrow Transplant 4:537, 1989
19. Ma DD, Varga DE, Biggs JC: Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation. Leuk Res 11:141, 1987
20. Arnold R, Schmeiser T, Heit W, Frickhofen N, Pabst G, Heimpel H, Kubanek B: Hemopoietic reconstitution after bone marrow transplantation. Exp Hematol 14:271, 1986
21. Faille A, Maraninchi D, Gluckman E, Devergie A, Balitrand N, Ketels F, Dresch C: Granulocyte progenitor compartments after allogeneic bone marrow grafts. Scand J Haematol 26:202, 1981
22. Atkinson K, Norrie S, Chan P, Downs K, Biggs J: Lack of correlation between nucleated bone marrow cell dose, marrow CFU-GM dose or marrow CFU-E dose and the rate of HLA-identical sibling marrow engraftment. Br J Haematol 60:245, 1985
23. Emminger W, Emminger Schmidmeier W, Hocker P, Hint-Erberger W, Gadner H: Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 4:415, 1989
24. Brandwein JM, Callum J, Sutcliffe SB, Scott JG, Keating A: Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 6:291, 1990
25. Stewart FM, Kaiser DL, Ishitani KP, Pirsch GW, Niskanen E: Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation. Exp Hematol 17:974, 1989
26. Visani G, Dinota A, Verlicchi F, Bandini G, Ricci P, Motta MR, Rizzi S, Lemoli RM, Poluzzi C, Gherlinzoni F: Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: Comparison of different parameters in predicting the kinetics of haematological recovery. Bone Marrow Transplant 3:599, 1988
27. Barrett AJ, Adams J: A proliferative defect of human bone marrow after transplantation. Br J Haematol 49:159, 1981
28. Li S, Champlin R, Fitchen JH, Gale RP: Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation. J Clin Invest 75:234, 1985
29. Simmovitch L, Till JE, McCulloch EA: Decline in the colony forming ability of marrow cells subjected to serial transplantation into irradiated mice. J Cell Comp Physiol 64:23, 1964
30. Schofield R, Lord BI, Kyffin S, Gilbert CW: Self maintenance capacity of CFU-S. J Cell Physiol 103:355, 1980
31. Schofield R, Dexter TM, Lord BI, Testa NG: Comparison of haemopoiesis in young and old mice. Mech Ageing Dev 34:1, 1986